![Malcolm McKay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Malcolm McKay worked as Vice President of Regulatory Affairs at Celtrix Pharmaceuticals, Inc. from 1996 to 2000.
He then worked as Vice President of Regulatory Affairs at VIVUS, Inc. before becoming Vice President of Corporate Compliance at InterMune, Inc. from 2003 to 2007.
McKay holds a doctorate degree from the University of London.
Precedenti posizioni note di Malcolm McKay
Società | Posizione | Fine |
---|---|---|
INTERMUNE INC | Responsabile della Conformità | 01/01/2007 |
Celtrix Pharmaceuticals, Inc.
![]() Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The company is based in Santa Clara, CA. | Consigliere Generale | 01/01/2000 |
VIVUS, INC. | Consigliere Generale | - |
Formazione di Malcolm McKay
University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
VIVUS, Inc.
![]() VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
InterMune, Inc.
![]() InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Celtrix Pharmaceuticals, Inc.
![]() Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The company is based in Santa Clara, CA. | Health Technology |
- Borsa valori
- Insiders
- Malcolm McKay